Thus, understanding this key axis in PD-L1 upregulation may contribute towards creating new therapeutic strategies, since targeting the PD-L1/PD-1 pathway has consistently shown significant and promising therapeutic efficacy in patients with advanced cancers [120]. Here, CD274 is linked to cancer.